Breadcrumb AMCP.org Policy & Advocacy Letters, Statements & Analysis AMCP Submits Comments to CMS on Medicare and Medicaid Programs; Regulation to Require Drug Pricing Transparency AMCP Submits Comments to CMS on Medicare and Medicaid Programs; Regulation to Require Drug Pricing Transparency 12/17/18 Tweet this pagePost this page on FacebookPost this page on LinkedInEmail this pagePrint this page AMCP Submits Comments to CMS on Medicare and Medicaid Programs; Regulation to Require Drug Pricing Transparency.pdf Tweet this pagePost this page on FacebookPost this page on LinkedInEmail this pagePrint this page